Lab Values: Normal vs. Optimal

Comparing Traditional Lab Ranges to a Functional Medicine Approach

If you've ever been told, "Everything looks normal," after getting blood work—even though you feel far from your best—you're not alone. Traditional medicine typically uses broad, statistical reference ranges to determine whether lab results are “normal.” But in functional medicine, we ask a deeper question: Are your levels optimal for your health, symptoms, and goals?

This difference in philosophy can drastically impact hormone therapy, thyroid treatment, and early detection of chronic disease—especially for patients seeking bioidentical hormone optimization.

What Does “Normal” Actually Mean?

Laboratory “normal” reference ranges are based on statistical averages from large populations—including people who may already have underlying health issues[^1]. These ranges don’t necessarily reflect what is healthy, balanced, or ideal—they simply show what’s common.

For instance, Labcorp’s most recent update to its free testosterone reference range for women lists the low end as 0.0 pg/mL, meaning a woman with no detectable testosterone could still be considered "within normal limits"[^2]. Yet testosterone plays a critical role in mood, energy, libido, bone density, and cognition—and many women with levels that low report feeling drained, depressed, and unable to build or maintain muscle[^3].

Symptomatic in the “Normal” Range: A Common Story

It’s increasingly clear in the research that patients can experience significant symptoms despite being within “normal” lab values. This is especially true for hormone markers like testosterone, thyroid hormones, and insulin.

For Men: “Low-Normal” Testosterone Still Causes Symptoms

While the lower end of “normal” total testosterone in men may fall around 300 ng/dL, many men begin to experience symptoms of androgen deficiency—including low energy, brain fog, mood changes, and decreased sexual function—at levels far above that threshold[^4].

In fact, research suggests that men tend to feel and function better when their testosterone levels are in the upper half of the reference range or even slightly above it[^5]. The EMAS (European Male Aging Study) showed that symptoms correlate more closely with free testosterone levels than total testosterone—and that many men and women with "normal" labs are still symptomatic[^6].

For Women: Hormonal Imbalance Missed by Traditional Testing

Women in premenopause/perimenopause and menopause are frequently told their labs are fine—even when experiencing night sweats, anxiety, irregular cycles, and brain fog. Hormone fluctuations can occur well before levels fall outside of normal ranges. Furthermore, key markers like progesterone, estradiol, testosterone, and thyroid can shift subtly but meaningfully—often missed by a conventional interpretation that doesn’t consider symptoms and even mishandled by other providers treating hormones, but lacking a deeper understanding of how hormone replacement should be navigated.

Thyroid Function: Missed Diagnoses in “Normal” Ranges

One of the most common conditions where this misalignment occurs is Hashimoto’s thyroiditis, an autoimmune thyroid disorder. Early signs, like rising TPO antibodies, can precede changes in TSH (thyroid-stimulating hormone) by years[^7]. Yet many patients are not treated—or even monitored—until overt hypothyroidism develops and significant thyroid damage has occurred.

Even within the “normal” TSH range, values above 2.5 mIU/L have been associated with fatigue, weight gain, and depressive symptoms in some patients, particularly women[^8].

 Why Functional Medicine Focuses on “Optimal” Ranges

In functional and integrative medicine, we don’t stop at “normal.” We ask:

• Are your levels optimal for how you want to feel?

• Do your labs explain your symptoms—or do they miss them?

• Can we act earlier to prevent disease, not just treat it later?

We interpret labs in the context of symptoms, history, and lifestyle, rather than just comparing numbers to population averages. We aim for tight, evidence-informed ranges where the body functions best, particularly for hormones, thyroid markers, and metabolic indicators like insulin and ferritin.

Optimal Ranges: Grounded in Evidence, Not Guesswork

Contrary to what some may assume, optimal lab ranges used in functional medicine are not arbitrary. They are increasingly supported by a growing body of high-quality literature, including:

• Randomized controlled trials (RCTs) comparing symptom resolution and metabolic outcomes at various hormone levels[^9]

• Longitudinal studies that track health outcomes based on hormone or metabolic marker levels over decades[^10]

• Research showing that patients with lab values in the upper half or quartile of “normal” ranges often have better quality of life, cardiovascular health, cognitive function, and longevity[^4][^5][^6]

Unfortunately, conventional medicine is slower to adapt to this evolving evidence base. Lab reference ranges are typically reviewed infrequently and often rely on epidemiological baselines, not outcome-based thresholds. That means what’s statistically “normal” today might still be clinically suboptimal or even harmful in the long term.

In contrast, clinics like VANTAGE HEALTH actively apply the latest peer-reviewed research to guide patient care, aiming for the ranges that are proven to promote wellness, not just avoid disease.

The Power of Optimal Hormone Support

Whether it’s a woman with zero testosterone being told she’s fine, or a man with “low-normal” testosterone and classic hypogonadal symptoms, patients often experience symptom relief, improved energy, mood, and sexual function when hormone levels are brought into optimal—not just normal—ranges.

This is the philosophy behind VANTAGE HEALTH’S Bioidentical Hormone Replacement Therapy Programs: precision, personalization, and proactive care.

Final Thoughts: Don’t Settle for “Normal”

“Normal” is just average or often less than average. But you deserve more than average health. By embracing a functional medicine approach to lab interpretation, we help patients move beyond numbers—toward true wellness, symptom relief, and disease prevention.

If you’re tired of being told “everything looks fine” when you know something is off, we’re here to help you find your optimal.

Works Cited

1. Cembrowski, George S., and Wallace H. Fung. “Statistical Methods for Determining Reference Intervals.” Clinical Chemistry, vol. 47, no. 2, 2001, pp. 267–70. https://academic.oup.com/clinchem/article/47/2/267/5629249

2. Labcorp. “Free Testosterone, Women and Children.” Labcorp Test Menu, 2024, https://www.labcorp.com

3. Davis, Susan R., et al. “Global Consensus Position Statement on the Use of Testosterone Therapy for Women.” Climacteric, vol. 22, no. 5, 2019, pp. 429–45. https://doi.org/10.1080/13697137.2019.1637074

4. Bhasin, Shalender, et al. “Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline.” Journal of Clinical Endocrinology & Metabolism, vol. 103, no. 5, 2018, pp. 1715–44. https://doi.org/10.1210/jc.2018-00229

5. Morgentaler, Abraham. “Guidelines for Male Testosterone Therapy: A Clinician’s Perspective.” Journal of Sexual Medicine, vol. 17, no. 11, 2020, pp. 1996–2001. https://doi.org/10.1016/j.jsxm.2020.07.015

6. Wu, Frederick C., et al. “Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men.” New England Journal of Medicine, vol. 363, no. 2, 2010, pp. 123–35. https://doi.org/10.1056/NEJMoa0911101

7. Burek, C. L., et al. “Early Autoimmune Events in Thyroiditis.” Autoimmunity Reviews, vol. 10, no. 3, 2011, pp. 166–71. https://doi.org/10.1016/j.autrev.2010.10.001

8. Vanderpump, Mark P. “The Epidemiology of Thyroid Disease.” British Medical Bulletin, vol. 99, 2011, pp. 39–51. https://doi.org/10.1093/bmb/ldr030

9. Grossmann, Mathis, and Gary Wittert. “Testosterone Treatment and Cardiovascular Risk.” Trends in Endocrinology & Metabolism, vol. 29, no. 3, 2018, pp. 140–57. https://doi.org/10.1016/j.tem.2017.11.006

10. Fabbri, Elena, et al. “Low Circulating Anabolic Hormones and Loss of Muscle Strength and Mass in Older Persons: The InCHIANTI Study.” The Journal of Clinical Endocrinology & Metabolism, vol. 100, no. 1, 2015, pp. 90–96. https://doi.org/10.1210/jc.2014-1852